CSE New Listing - Better Life Pharma Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

December 16, 2019 9:00 AM EST | Source: InvestmentPitch Media

Vancouver, British Columbia--(Newsfile Corp. - December 16, 2019) - Better Life Pharma Inc. (CSE: BETR) is one of the latest new listings on the Canadian Securities Exchange, having previously traded as Pivot Pharmaceuticals. BetterLife Pharma Inc. is a science-based innovative medical wellness company aspiring to offer high-quality preventive and self-care products to its customers.

For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Better Life" in the search box. 



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_ht6i9dws/New-Listing-Better-Life-Pharma-Inc-CSEBETR

BetterLife has developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies that are unique, patent protected and with clear superior benefits to the user such as high absorption, low bioburden and ease of use. The company is uniquely positioned to execute on its brand leader strategy in its main markets in Germany, US and Canada.

Dr. Toni Rinow, CEO, stated: "2020 marks an important point in our evolution and this new branding reflects our commitment to commercialize science-based innovative medical formulations and to offer high quality preventive and self-care solutions to our customers. We are leveraging our expanding drug delivery IP portfolio and customized formulation capabilities to develop products in compliance with the highest quality standards, respecting tight specifications from raw material to final product and rigorously adhering to best practices."

BetterLife recognizes the importance of creating a market leading brand and is actively working with Joseph Mimran & Associates to brand and market BetterLife's world class phytocannabanoid and nutraceutical products with an immediate focus on BetterLife's product roll out in the US in Q1 2020.

For more information, please visit the company's website www.aBetterLifePharma.com, contact Dr. Toni Rinow, CEO, at 438-884-8841 or by email at toni.rinow@bLifePharma.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community.

The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors. For more information please watch this video.

CONTACT:

InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50811

info